Kristi Gamarel and Sari Reisner, along with researchers from Yale and Emory, are calling out a critical gap in HIV research: the exclusion of transgender individuals. In a new commentary for The Lancet HIV, they warn that recent government rollbacks threaten both trans health and public health overall. The authors stress that including transgender people in HIV research is vital for ensuring its integrity and success. Read on to discover why resisting trans representation isn’t just unethical—it’s a barrier to ending the HIV epidemic.
